These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Aiduk C. Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929 [Abstract] [Full Text] [Related]
26. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial. Groenvold M, Fayers PM, Petersen MA, Mouridsen HT. Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325 [Abstract] [Full Text] [Related]
27. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Cancer; 2006 Jan 01; 106(1):35-41. PubMed ID: 16333848 [Abstract] [Full Text] [Related]
36. Body weight correlates with mortality in early-stage breast cancer. Enger SM, Greif JM, Polikoff J, Press M. Arch Surg; 2004 Sep 01; 139(9):954-58; discussion 958-60. PubMed ID: 15381612 [Abstract] [Full Text] [Related]
37. Association of surgery with improved survival in stage IV breast cancer patients. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Ann Surg; 2008 May 01; 247(5):732-8. PubMed ID: 18438108 [Abstract] [Full Text] [Related]
39. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Nisticò C, Cuppone F, Bria E, Fornier M, Giannarelli D, Mottolese M, Novelli F, Natoli G, Cognetti F, Terzoli E. Anticancer Drugs; 2006 Nov 01; 17(10):1193-200. PubMed ID: 17075319 [Abstract] [Full Text] [Related]